Astellas Pharma Aktie
| 8,81EUR | 0,02EUR | 0,27% |
WKN: 856273 / ISIN: JP3942400007
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Personal am Ende des Jahres | 15 883 | 15 455 | 14 522 | 14 484 | 14 754 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 81,90 | 80,85 | 89,26 | 104,85 | 108,69 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Summe Umlaufvermögen | 867 514 | 872 588 | 923 354 | 1 049 954 | 1 194 730 | 1 201 349 |
| Summe Anlagevermögen | 1 702 500 | 1 664 379 | 1 673 052 | 1 707 961 | 2 601 704 | 2 344 681 |
| Summe Aktiva | 2 318 160 | 2 273 628 | 2 332 395 | 2 456 518 | 3 569 603 | 3 339 544 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 413 332 | 278 264 | 212 744 | 200 007 | 1 005 716 | 831 426 |
| Summe Fremdkapital | 1 028 990 | 887 514 | 872 086 | 948 564 | 1 973 616 | 1 826 290 |
| Summe Eigenkapital | 1 289 168 | 1 386 115 | 1 460 308 | 1 507 954 | 1 595 988 | 1 513 255 |
| Summe Passiva | 2 318 158 | 2 273 629 | 2 332 394 | 2 456 518 | 3 569 604 | 3 339 544 |
Adresse
| 2-5-1 Nihonbashi-Honcho, 103-8411 Tokyo | |
| Telefon | +81 (3) 3244-3000 |
| Internet | https://www.astellas.com/jp/ |
Management
|
Adam John Pearson
Chief Strategy Officer |
|
Claus Gerhard Zieler
Chief Commercial & Medical Affairs Officer |
|
Eisuke Nozawa
Vice President-Regulatory Affairs |
|
Eriko Sakurai
Independent Outside Director |
|
Katsuyoshi Sugita
Representative Director & Chief People Officer |
|
Kenji Yasukawa
Chairman |
|
Kitamura Atsushi
Chief Financial Officer |
|
Masahiro Miyazaki
Independent Outside Director |
|
Mika Nakayama
Independent Outside Director |
|
Naoki Okamura
President, CEO & Representative Director |
|
Nick Eshkenazi
Chief Digital & Transformation Officer |
|
Rao V. Mantri
Chief Manufacturing Officer |
|
Rie Akiyama
Independent Outside Director |
|
Rika Hirota
Director |
|
Tadaaki Taniguchi
Chief Research & Development Officer |
|
Takashi Tanaka
Independent Outside Director |
|
Tatjana Dragovic
General Counsel, Chief Ethics & Compliance Officer |
|
Tomoko Aramaki
Independent Outside Director |
|
Yasuhiro Fujita
Head-Accounting & Global Business Solutions |
|
Yoichi Ohno
Independent Outside Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
